2-Amino-3-phenyl-propionamide

ID: ALA350320

Chembl Id: CHEMBL350320

Cas Number: 5241-58-7

PubChem CID: 445694

Product Number: S47884

Max Phase: Preclinical

Molecular Formula: C9H12N2O

Molecular Weight: 164.21

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  NC(=O)[C@@H](N)Cc1ccccc1

Standard InChI:  InChI=1S/C9H12N2O/c10-8(9(11)12)6-7-4-2-1-3-5-7/h1-5,8H,6,10H2,(H2,11,12)/t8-/m0/s1

Standard InChI Key:  OBSIQMZKFXFYLV-QMMMGPOBSA-N

Alternative Forms

  1. Parent:

Associated Targets(non-human)

Cckar Cholecystokinin receptor (88 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Tacr1 Neurokinin 1 receptor (938 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 164.21Molecular Weight (Monoisotopic): 164.0950AlogP: 0.04#Rotatable Bonds: 3
Polar Surface Area: 69.11Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 8.02CX LogP: 0.27CX LogD: -0.44
Aromatic Rings: 1Heavy Atoms: 12QED Weighted: 0.66Np Likeness Score: 0.03

References

1. Horwell DC, Beeby A, Clark CR, Hughes J..  (1987)  Synthesis and binding affinities of analogues of cholecystokinin-(30-33) as probes for central nervous system cholecystokinin receptors.,  30  (4): [PMID:3560164] [10.1021/jm00387a027]
2. Fransson R, Botros M, Sköld C, Nyberg F, Lindeberg G, Hallberg M, Sandström A..  (2010)  Discovery of dipeptides with high affinity to the specific binding site for substance P1-7.,  53  (6): [PMID:20178322] [10.1021/jm901352b]
3. Sriram S, Lee JH, Mai BK, Jiang Y, Kim Y, Yoo YD, Banerjee R, Lee SH, Lee MJ..  (2013)  Development and characterization of monomeric N-end rule inhibitors through in vitro model substrates.,  56  (6): [PMID:23432203] [10.1021/jm400046q]

Source